CONMED Corp. (CNMD)
51.50
-1.33
(-2.52%)
USD |
NYSE |
Nov 06, 16:00
51.45
-0.05
(-0.10%)
After-Hours: 20:00
CONMED Shareholders Equity (Quarterly) : 1.060B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.060B |
| June 30, 2026 | 1.041B |
| March 31, 2026 | 1.018B |
| December 31, 2025 | 1.033B |
| September 30, 2025 | 1.008B |
| June 30, 2025 | 1.003B |
| March 31, 2025 | 977.64M |
| December 31, 2024 | 962.68M |
| September 30, 2024 | 932.90M |
| June 30, 2024 | 881.83M |
| March 31, 2024 | 854.66M |
| December 31, 2023 | 834.22M |
| September 30, 2023 | 796.20M |
| June 30, 2023 | 780.19M |
| March 31, 2023 | 752.45M |
| December 31, 2022 | 745.54M |
| September 30, 2022 | 716.34M |
| June 30, 2022 | 672.97M |
| March 31, 2022 | 789.55M |
| December 31, 2021 | 785.44M |
| September 30, 2021 | 755.68M |
| June 30, 2021 | 744.50M |
| March 31, 2021 | 725.57M |
| December 31, 2020 | 709.04M |
| September 30, 2020 | 683.14M |
| Date | Value |
|---|---|
| June 30, 2020 | 674.90M |
| March 31, 2020 | 701.64M |
| December 31, 2019 | 710.47M |
| September 30, 2019 | 700.92M |
| June 30, 2019 | 697.01M |
| March 31, 2019 | 693.06M |
| December 31, 2018 | 662.27M |
| September 30, 2018 | 652.66M |
| June 30, 2018 | 648.19M |
| March 31, 2018 | 642.63M |
| December 31, 2017 | 631.43M |
| September 30, 2017 | 589.67M |
| June 30, 2017 | 582.36M |
| March 31, 2017 | 575.52M |
| December 31, 2016 | 580.58M |
| September 30, 2016 | 584.18M |
| June 30, 2016 | 579.73M |
| March 31, 2016 | 582.29M |
| December 31, 2015 | 585.07M |
| September 30, 2015 | 577.42M |
| June 30, 2015 | 578.09M |
| March 31, 2015 | 574.09M |
| December 31, 2014 | 581.30M |
| September 30, 2014 | 592.72M |
| June 30, 2014 | 602.15M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Globus Medical, Inc. | 4.796B |
| Becton, Dickinson & Co. | 24.68B |
| Abbott Laboratories | 51.03B |
| AngioDynamics, Inc. | 163.96M |
| Alphatec Holdings, Inc. | 21.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.304B |
| Total Liabilities (Quarterly) | 1.245B |
| Debt to Equity Ratio | 0.7697 |
| Current Ratio | 1.486 |
| Net Debt Paydown Yield | 0.96% |